(Lauren Neergard/ CBC MNews) — Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.

Eli Lilly and Co. is seeking U.S. Food and Drug Administration (FDA) approval of donanemab. If cleared, it would be only the  …

(Agence France-Presse/ Science Alert) — The US drug regulator gave full approval to a new Alzheimer’s medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.

​Leqembi, developed jointly by Japan’s Eisai  …

(Natasha O’Neill/ CTV News) — A breakthrough drug approved in the U.S. to treat Alzheimer’s could soon be available in Canada.

Health Canada started the approval process for drug lecanemab in May. The drug, also known by the brand name Leqembi, is for the treatment of Alzheimer’s itself – not just the  …

(Gina Kolata/ New York Times) — The patients had metastatic breast cancer that had been progressing despite rounds of harsh chemotherapy. But a treatment with a drug that targeted cancer cells with laserlike precision was stunningly successful, slowing tumor growth and extending life to an extent rarely seen with advanced  …

(Sean Boynton/ Global News) — Health Canada is warning the public not to use the deworming drug ivermectin to treat COVID-19, particularly the version that is used for animals.

The health agency said Tuesday that it has “received concerning reports of the use of veterinary ivermectin to prevent or treat” the novel  …